Recruiting studies: Linezolid

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Phase 2/Phase 3 · 6 location(s) · University of California, San Francisco · NCT06441006 Linezolid Plus Standard of Care
NA · 12 location(s) · University Hospital, Basel, Switzerland · NCT06958835 Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB
Phase 2 · 11 location(s) · Global Alliance for TB Drug Development · NCT07672405 Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Phase 2 · 13 location(s) · Gates Medical Research Institute · NCT07525427 Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05534750 Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and O
Phase 3 · 14 location(s) · MicuRx · NCT05369052 Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
Phase 3 · 13 location(s) · ANRS, Emerging Infectious Diseases · NCT04145258 Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) Durin
Phase 4 · 1 location(s) · Marco Schiuma · NCT07477119 Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susc
Phase 2 · 4 location(s) · Gates Medical Research Institute · NCT07517445 In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive C
Phase N/A · 1 location(s) · Niguarda Hospital · NCT07230041 A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Phase 3 · 35 location(s) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT07209761 Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard
Phase 2 · 18 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05383742 Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
NA · 1 location(s) · Albert Einstein College of Medicine · NCT06590428 Linezolid or Vancomycin Surgical Site Infection Prophylaxis
Phase 4 · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT05571722

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.